David Y. Liu, Chief Scientific Officer at Protagonist Therapeutics, Inc (PTGX), sold 7,000 shares at $16.97 ($119K) on 2017-11-13, disclosed to the SEC on 2017-11-15.
Open-market sale of $119k PTGX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.97 | 3,500 | $59K | 50.0% |
| 2 | $16.97 | 3,500 | $59K | 50.0% |
| Total | $16.97 avg | 7,000 | $119K | 100% |
| Filing → |
| PTGX | SELL | 2019-03-04 | $7K | — | Filing → |
| PTGX | SELL | 2019-02-08 | $30K | — | Filing → |
| PTGX | SELL | 2018-03-13 | $75K | — | Filing → |